Literature DB >> 163843

Immunochemical heterogeneity of calcitonin in plasma.

L J Deftos, B A Roos, D Bronzert, J G Parthemore.   

Abstract

Calcitonin was measured in the plasma of 13 patients with medullary throid carcinoma and one patient with a calcitonin-producing islet cell carcinoma of the pancreas. The hormone was measured by the simultaneous application of two calcitonin antisera which had differing specificity. Calcitonin measurements were also made of gel filtration (Bio Gel P30) fractions of plasma samples. Although the two antisera were of comparable sensitivity for the measurement of human calcitonin standards, they reacted differently with the calcitonin in the plasma samples. One antiserum (LD-1) gave consistently higher estimations of hormone concentration in the plasma of patients with medullary thyroid carcinoma than the other (LD-26). By contrast, the concentration of calcitonin from the islet cell carcinoma of the pancreas was higher in the LD-26 assay. Multiple gel filtration peaks of immunoreactive calcitonin activity were present in both thyroidal and nonthyroidal calcitonin. Furthermore, the two different antisera identified differing immunochemical peaks of calcitonin activity for agiven plasma sample. These findings demonstrate the presence of immunochemical heterogeneity in plasma calcitonin and suggest the presence of immunological differences between thyroidal and nonthyroidal calcitonin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163843     DOI: 10.1210/jcem-40-3-409

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  The action and control of the calcium-regulating hormones.

Authors:  I MacIntyre
Journal:  J Endocrinol Invest       Date:  1978-07       Impact factor: 4.256

Review 2.  Cell differentiation and the biological significance of inappropriate tumour products.

Authors:  M L Ellison
Journal:  Proc R Soc Med       Date:  1977-12

3.  Calcitonin secretion in renal disease.

Authors:  J C Lee; J G Parthemore; L J Deftos
Journal:  Calcif Tissue Res       Date:  1977-05

4.  Secretion by glucagonomas of a possible glucagon precursor.

Authors:  G C Weir; E S Horton; T T Aoki; D Slovik; J Jaspan; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

5.  The regulation of calcitonin in normal human plasma as assessed by immunoprecipitation and immunoextraction.

Authors:  J G Parthemore; L J Deftos; D Bronzert
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

6.  Hypercalcitoninemia in pancreatitis--evidence for immunochemical heterogeneity.

Authors:  D B Cannarozzi; R K Donabedian
Journal:  Experientia       Date:  1977-04-15

7.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Tumour calcitonin. Interaction with specific calcitonin receptors.

Authors:  J Ham; M L Ellison; J Lumsden
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

9.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

10.  Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.

Authors:  J Y Reginster; R Deroisy; A Albert; D Denis; M P Lecart; J Collette; P Franchimont
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.